📞 858-622-7200office@diaendo.comLa Jolla · Poway · La MesaDiabetes and Endocrine Specialists Medical Group
Testosterone

Low testosterone: a syndrome, not a number

Fatigue, low mood and poor concentration are the symptoms men bring in. On the best population evidence, they are not the symptoms that track testosterone.

Two statements sound alike and are not: having symptoms that could be caused by low testosterone, and having documented testosterone deficiency. The first describes fatigue, flat mood, low libido, poor concentration and declining strength, a cluster so common in middle-aged men that it approaches a description of middle age itself. The second describes a specific endocrine condition, defined by symptoms together with consistently low, correctly measured testosterone and a cause that has been looked for. Most men who arrive in the first category are treated as though they were in the second, and almost everything that goes wrong in this field happens in that gap.

The words and what they mean

TermWhat it means
HypogonadismThe term used in guidelines: the gonads are not producing adequate testosterone, sperm, or both.
Testosterone deficiencyUsed more or less interchangeably with hypogonadism in the American literature, and the term the AUA prefers.
Low TA term that entered general use through direct-to-consumer advertising. It can denote a diagnosis, a number or a feeling, and therefore denotes none of them precisely.
Andropause, male menopauseBest discarded. Menopause is a discrete event with a clear hormonal signature in essentially all women. Testosterone declines gradually, variably, in some men and not others, driven substantially by health status rather than by age itself.
Late-onset and functional hypogonadismContested. The Endocrine Society's July 2026 statement rejects both terms, saying they "are hard to define operationally and blur the line between treatable disease and normal aging." The European Academy of Andrology built a guideline around functional hypogonadism as a real, treatable category.

That last disagreement is live between major societies, and it is covered at Why Experts Don't Always Agree.

Why the symptoms are unreliable

The European Male Ageing Study examined 3,369 community-dwelling men aged 40 to 79 across eight European centres. The investigators took 32 candidate symptoms — sexual, physical and psychological — and asked which were independently associated with testosterone level rather than merely co-occurring with it. Three survived, and all three were sexual: poor morning erections, low sexual desire and erectile dysfunction. Fatigue, low energy, reduced vigour, poor physical performance, low mood and sleep disturbance were associated with age and accumulating comorbidity instead. The complaints that most often send a man to have his testosterone measured are, on the best population evidence available, not the complaints that track testosterone.

On that basis the study proposed a definition of late-onset hypogonadism: at least three sexual symptoms, plus total testosterone below 11 nmol/L (3.2 ng/mL) and free testosterone below 220 pmol/L (64 pg/mL). The authors presented these as the sharp edge of a graded probability rather than a switch, giving ranges of 8.0 to 13.0 nmol/L for total and 160 to 280 pmol/L for free testosterone. A companion EMAS analysis applying the definition found a prevalence of 2.1% — 63 of 2,966 men over 40 — against a background in which, depending on threshold and population, somewhere between 10% and 40% of men have a biochemically low testosterone. The distance between having a low number and having a syndrome is the subject of this site.

Symptom questionnaires

The ADAM questionnaire and the Aging Male Symptoms scale are widely used, including as the entry point of commercial screening funnels. In one validation cohort, ADAM had a sensitivity of 90.1% and a specificity of 47.3%. It therefore rarely misses a man who does have low testosterone, and it also flags roughly half of the men who do not. A questionnaire with those properties is useful for deciding whether to measure and unusable for deciding whether to treat.

The low-T trap

The conditions that cause these symptoms are frequently the same conditions that lower testosterone. A man presents with fatigue, low libido and low mood, and his testosterone comes back at 280 ng/dL. If the driver is obstructive sleep apnoea, opioids, depression or fifteen extra kilograms, that condition is producing both the symptoms and the low number, and treating the number leaves the cause in place. The confounder is not sitting beside the finding; it is upstream of both.

What is really going onHow it lowers testosteroneSymptoms it produces directly
ObesityAromatase in adipose tissue; insulin resistance suppresses SHBG and the axisFatigue, low libido, ED, low mood, poor performance
Obstructive sleep apnoeaDisrupted sleep architecture; heavily confounded with obesityFatigue, poor concentration, low mood, low libido, ED
DepressionHPG axis suppression; also a consequence of low testosteroneThe entire non-sexual symptom cluster
OpioidsDirect central suppression of GnRH and gonadotropinsFatigue, low libido, ED, low mood
GlucocorticoidsHPG axis suppressionFatigue, weakness, mood change
Chronic illnessSystemic inflammation, catabolism, medication effectsFatigue, weakness, low libido
Chronic sleep lossTestosterone secretion is sleep-dependentFatigue, poor concentration, irritability, low libido
Under-eating, energy deficitCentral suppression of the reproductive axisFatigue, low libido, poor recovery
OvertrainingEnergy deficit plus inadequate recoveryFatigue, declining performance, low libido
AlcoholTesticular toxicity, hepatic effects, central suppressionFatigue, low mood, ED, poor sleep
Thyroid diseaseAlters SHBG in both directionsFatigue, weight change, low mood, cognitive slowing
Pituitary diseaseReduced LH and FSH outputFatigue, low libido, ED, sometimes headache or visual change

Every row is a situation in which testosterone is the wrong first move, and each is covered at When Testosterone Isn't the Answer.

Research presented at ENDO 2026 by Sinha and Papaleontiou at Michigan Medicine reviewed 200 men prescribed testosterone in outpatient primary care between 2020 and 2025. Twelve percent had a guideline-concordant diagnostic workup, meaning two low morning testosterone measurements, LH and FSH, and screening for contraindications. Within the cohort, 55% had obstructive sleep apnoea, 63% were obese, 52% had hypertension, 40% had depression, 28% had diabetes, and 4% had a prior diagnosis of prostate cancer. These were men with several available explanations for their symptoms, receiving a hormone.

Primary and secondary: where the problem sits

A low result raises two questions, and the second is the useful one: is testosterone low, and why. In primary hypogonadism the testes themselves are failing, the pituitary signals harder, and LH and FSH are high; causes include Klinefelter syndrome, testicular injury or torsion, mumps orchitis, chemotherapy or radiation. In secondary hypogonadism the testes are capable but under-instructed, so LH and FSH are low or inappropriately normal; causes include pituitary adenoma, hyperprolactinaemia, hypothalamic disease, opioids, glucocorticoids, severe systemic illness, obesity and sleep disorders.

The distinction costs one blood test and determines nearly everything downstream: whether imaging is needed, whether the cause is reversible, whether fertility can be preserved, and whether testosterone is the right drug at all. In the Michigan cohort, measuring LH and FSH was among the steps most often skipped.

Klinefelter syndrome is the most common cause of primary hypogonadism, affecting roughly 1 in 500 to 1 in 1,000 males, and up to two-thirds of affected men are never diagnosed — only around 26 to 37% are ever identified, fewer than 10% before puberty, with a mean age at diagnosis around 30. A man with genuinely low testosterone, high LH and FSH, small firm testes and infertility has an indication for a karyotype rather than for a prescription.

Age, health, and what the decline means

Testosterone does decline with age, at roughly 1.0 to 1.5% per year on average, but three findings complicate the view that low testosterone is simply what happens to older men. Most older men are not deficient: the VA Pharmacy Benefits Management Services' January 2026 Recommendations for Use note that around 63% of men over 70 remain within the reference interval. And the decline is mostly not about age as such — longitudinal analysis from the European Male Ageing Study found the age-related fall resides "overwhelmingly in accumulating co-morbidities, including obesity, and only a minor direct association with ageing per se." A man's testosterone at 65 reflects what has happened to his health, not merely how long he has been alive.

The third finding is that the population may be shifting. A Massachusetts Male Aging Study analysis published in 2007, drawing on 2,769 observations across 1,532 men over three survey waves, found a substantial, age-independent decline in testosterone across birth cohorts, not explained by changes in body weight or smoking, and a Danish study found something similar. A recurring critique is that changing immunoassay methods across survey waves could produce an apparent secular trend, which has not been resolved.

What a real diagnosis requires

- Symptoms consistent with deficiency, with more weight on the sexual symptoms, which are the ones that track testosterone. - Consistently low, correctly measured testosterone — at least two early-morning fasting samples on a standardised assay. See How Testosterone Should Actually Be Tested. - LH and FSH, to locate the problem. - A cause, or a serious search for one. See Why Is Testosterone Low?. - Reversible contributors identified and addressed. - Fertility intentions established before treatment. See TRT and Fertility.

The Endocrine Society's July 2026 statement is explicit that symptoms alone are not diagnostic, and that diagnosis rests on symptoms plus at least two early-morning fasting tests using a standardised assay.

When the symptoms are real and testosterone is not the cause

Men in this position are handled badly in two opposite directions. One failure is being told the testosterone is low and handed a prescription that treats a number while a genuine problem continues. The other is being told the testosterone is normal and sent away with nothing, the cause of the symptoms left unexamined. Both treat the testosterone level as the whole question. A normal testosterone does not mean nothing is wrong; it means the answer lies elsewhere and someone should go and look for it, which is what an individual assessment at the practice is for.

Questions patients ask

If I am tired, I probably have low testosterone.

Fatigue is among the least specific symptoms in medicine, and it was not independently associated with testosterone in the best population study available.

What the evidence showsThe European Male Ageing Study screened 32 candidate symptoms in 3,369 men and found only three, all sexual, independently associated with testosterone level. Physical and psychological symptoms including fatigue tracked age and comorbidity instead.

What remains uncertainNo independent association is not the same as no relationship; comorbidity may mediate it, and the population was European men aged 40 to 79.

Bottom lineFatigue alone makes testosterone an unlikely explanation, and makes sleep, weight, mood, thyroid and alcohol likely ones.

Moderate

300 ng/dL is automatically low.

It is a threshold, not a verdict, and the societies do not agree on it.

What the evidence showsThe VA uses 264 ng/dL. The Endocrine Society's July 2026 statement cites a common threshold near 300. The EAU treats below 12 nmol/L (346 ng/dL) as likely hypogonadal. A 2025 cross-society analysis documented a spread of roughly 231 to 346 ng/dL.

What remains uncertainWhich threshold identifies the men who actually benefit from treatment.

Bottom lineA result near 300 opens a conversation rather than closing one.

Strong

400 ng/dL is too low for a man.

No. It sits comfortably within the normal range for healthy young men.

What the evidence showsIn a harmonised reference range built from 1,185 healthy non-obese men, the range for ages 19 to 39 was 264 to 916 ng/dL, with a median of 531 and a 5th percentile of 303.

What remains uncertainVery little. No guideline supports treating a man at 400 ng/dL.

Bottom lineAt 400 ng/dL with symptoms, the explanation is somewhere else.

Strong

A symptom questionnaire can tell me whether I have low testosterone.

It can indicate that measurement is worthwhile. It cannot establish a diagnosis.

What the evidence showsThe ADAM questionnaire showed a sensitivity of 90.1% and a specificity of 47.3% in one validation cohort, so it rarely misses deficiency and flags roughly half of the men who do not have it.

What remains uncertainPerformance varies substantially between populations.

Bottom lineUseful for deciding whether to test, not for deciding whether to treat.

Moderate

My testosterone is normal, so nothing is wrong.

The symptoms are real, and a normal result means the cause is elsewhere.

What the evidence showsThe symptoms attributed to low testosterone are produced by sleep disorders, depression, thyroid disease, anaemia, chronic illness, medications and inadequate sleep, all of which occur with normal testosterone. A high SHBG can also produce a normal total with a genuinely low free testosterone.

What remains uncertainWhether a subset of men have meaningful androgen resistance at normal levels. There is no validated way to identify them.

Bottom lineA normal result redirects the investigation rather than ending it.

Strong

Low testosterone is just part of getting older.

Some decline is usual. Deficiency is not, and most older men do not have it.

What the evidence showsTestosterone falls roughly 1.0 to 1.5% per year, but around 63% of men over 70 remain within the reference interval. EMAS longitudinal data attribute the decline "overwhelmingly" to accumulating comorbidity rather than to ageing itself.

What remains uncertainHow much decline is unavoidable in a man who stays genuinely healthy.

Bottom lineAge explains part of it and health explains more, and neither makes a low testosterone automatically normal or automatically a disease.

Moderate


Ready for testosterone care built on a diagnosis?

The first step is a full endocrine evaluation, not a prescription. We see patients across San Diego County and welcome referrals from other physicians.

Our endocrinologists evaluate low testosterone in La Jolla, La Mesa and Poway: low testosterone care at Diabetes & Endocrine Specialists.

WHO WE ARE

Physician-scientists. Board-certified endocrinologists. Your doctors.

Darius A. Schneider, MD, PhD

Darius A. Schneider, MD, PhD

Board-Certified Endocrinologist · ECNU

Physician-scientist in diabetes, obesity and metabolic medicine — evidence-first, individualized care.

Mba Uzoma Mba, MD, PhD

Mba Uzoma Mba, MD, PhD

Board-Certified Endocrinologist

Physician-scientist in endocrinology and metabolic health, committed to clear, evidence-based care.

CallRequest Appointment